AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Hugin)
Leiden, The Netherlands, December 1, 2008. Biotech company Pharming Group NV ("Pharming" or "The Company") (Euronext: PHARM) announced today that Prof. Dr. B.P.Th. Veltman has notified the Company that he will retire from the Board of Supervisory Directors ("BOSD") effective December 1, 2008. Reaching the age of 76, Dr. Veltman had already previously announced that he had plans to retire from the BOSD at the Annual General Meeting in 2009. Personal circumstances have led him to take this decision at this moment.
Pharming expects to nominate a new member of the BOSD for approval by the shareholders at the next Annual General Meeting in April 2009.
Mr Jaap Blaak, Chairman of Pharming's Board of Supervisory Directors said: "Pharming is very grateful to Dr. Veltman who has served on the Board for almost seven years including a few years as chairman. His extensive knowledge and experience in the Academic world as well as in several high-tech companies has been very important for Pharming's development over the last seven years. Dr. Veltman made many valuable contributions during this period. We regret, but understand and accept, his wish to retire at this moment."
About Pharming Group NV Pharming Group NV is developing innovative products for the treatment of genetic disorders, ageing diseases, specialty products for surgical ...